{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:22:15Z","timestamp":1784694135150,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10620-022-07491-y","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:06:59Z","timestamp":1650899219000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Characteristics of Patients with Crohn\u2019s Disease With or Without Perianal Fistulae in the CorEvitas Inflammatory Bowel Disease Registry"],"prefix":"10.1007","volume":"68","author":[{"given":"Yanni","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Delgado-Aros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell C.","family":"Valdecantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jud C.","family":"Janak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux M.","family":"Crabtree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-2186","authenticated-orcid":false,"given":"Ryan W.","family":"Stidham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"7491_CR1","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383:2652\u20132664.","journal-title":"N Engl J Med."},{"key":"7491_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ibd\/izy015","volume":"24","author":"SR Knowles","year":"2018","unstructured":"Knowles SR, Keefer L, Wilding H et al. Quality of life in inflammatory bowel disease: A systematic review and meta-analyses-part II. Inflamm Bowel Dis. 2018;24:966\u2013976.","journal-title":"Inflamm Bowel Dis."},{"key":"7491_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","volume":"325","author":"K Cushing","year":"2021","unstructured":"Cushing K, Higgins PDR. Management of Crohn disease: A review. J Am Med Assoc. 2021;325:69\u201380.","journal-title":"J Am Med Assoc."},{"key":"7491_CR4","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.3390\/jcm10235548","volume":"10","author":"F Rubbino","year":"2021","unstructured":"Rubbino F, Greco L, di Cristofaro A et al. Journey through Crohn\u2019s disease complication: From fistula formation to future therapies. J Clin Med. 2021;10:5548.","journal-title":"J Clin Med."},{"key":"7491_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12955-020-01622-7","volume":"18","author":"SO Adegbola","year":"2020","unstructured":"Adegbola SO, Dibley L, Sahnan K et al. Burden of disease and adaptation to life in patients with Crohn\u2019s perianal fistula: A qualitative exploration. Health Qual Life Outcomes. 2020;18:370.","journal-title":"Health Qual Life Outcomes."},{"key":"7491_CR6","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1111\/j.1572-0241.2008.02212.x","volume":"103","author":"KM Tarrant","year":"2008","unstructured":"Tarrant KM, Barclay ML, Frampton CMA, Gearry RB. Perianal disease predicts changes in Crohn\u2019s disease phenotype\u2014results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol. 2008;103:3082\u20133093.","journal-title":"Am J Gastroenterol."},{"key":"7491_CR7","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","volume":"139","author":"KT Thia","year":"2010","unstructured":"Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort. Gastroenterology. 2010;139:1147\u20131155.","journal-title":"Gastroenterology."},{"key":"7491_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","volume":"130","author":"L Beaugerie","year":"2006","unstructured":"Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn\u2019s disease. Gastroenterology. 2006;130:650\u2013656.","journal-title":"Gastroenterology."},{"key":"7491_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EV Jr, Tremaine WJ et al. The natural history of fistulizing Crohn\u2019s disease in Olmsted County Minnesota. Gastroenterology. 2002;122:875\u2013880.","journal-title":"Gastroenterology."},{"key":"7491_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn\u2019s disease in a population-based cohort. Dis Colon Rectum. 2012;55:773\u2013777.","journal-title":"Dis Colon Rectum."},{"key":"7491_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers G, Bergstrand O, Ewerth S, Holmstr\u00f6m B. Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease. Gut. 1980;21:525\u2013527.","journal-title":"Gut."},{"key":"7491_CR12","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1097\/MIB.0000000000000148","volume":"20","author":"I Molendijk","year":"2014","unstructured":"Molendijk I, Nuij VJ, van der Meulen-de Jong AE, van der Woude CJ. Disappointing durable remission rates in complex Crohn\u2019s disease fistula. Inflamm Bowel Dis. 2014;20:2022\u20132028.","journal-title":"Inflamm Bowel Dis."},{"key":"7491_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314918","volume":"67","author":"PG Kotze","year":"2018","unstructured":"Kotze PG, Shen B, Lightner A et al. Modern management of perianal fistulas in Crohn\u2019s disease: Future directions. Gut. 2018;67:1181\u20131194.","journal-title":"Gut."},{"key":"7491_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/apt.12906","volume":"40","author":"NA Yassin","year":"2014","unstructured":"Yassin NA, Askari A, Warusavitarne J et al. Systematic review: The combined surgical and medical treatment of fistulising perianal Crohn\u2019s disease. Aliment Pharmacol Ther. 2014;40:741\u2013749.","journal-title":"Aliment Pharmacol Ther."},{"key":"7491_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease. Gut. 2014;63:1381\u20131392.","journal-title":"Gut."},{"key":"7491_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrgastro.2017.104","volume":"14","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s J, Rimola J. Perianal fistulizing Crohn\u2019s disease: Pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14:652\u2013664.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"7491_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/codi.13311","volume":"18","author":"EJ de Groof","year":"2016","unstructured":"de Groof EJ, Sahami S, Lucas C et al. Treatment of perianal fistula in Crohn\u2019s disease: A systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment. Colorectal Dis. 2016;18:667\u2013675.","journal-title":"Colorectal Dis."},{"key":"7491_CR18","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","volume":"50","author":"WB Gaertner","year":"2007","unstructured":"Gaertner WB, Decanini A, Mellgren A et al. Does infliximab infusion impact results of operative treatment for Crohn\u2019s perianal fistulas? Dis Colon Rectum. 2007;50:1754\u20131760.","journal-title":"Dis Colon Rectum."},{"key":"7491_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10151-011-0759-4","volume":"15","author":"L Alessandroni","year":"2011","unstructured":"Alessandroni L, Kohn A, Cosintino R et al. Local injection of infliximab in severe fistulating perianal Crohn\u2019s disease: An open uncontrolled study. Tech Coloproctol. 2011;15:407\u2013412.","journal-title":"Tech Coloproctol."},{"key":"7491_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1111\/apt.14016","volume":"45","author":"C Ma","year":"2017","unstructured":"Ma C, Fedorak RN, Kaplan GG et al. Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn\u2019s disease: Real world experience from a multicentre cohort. Aliment Pharmacol Ther. 2017;45:1232\u20131243.","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07491-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:50:18Z","timestamp":1674852618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07491-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7491"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07491-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study design and conduct were the result of a collaborative effort between CorEvitas, LLC, and Boehringer Ingelheim. YF, SDA, and WCV are employed by Boehringer Ingelheim. PCM, JCJ, and MMC are employed by CorEvitas, LLC. RWS has received consultancy fees for AbbVie, Janssen, Merck, Takeda, Eli Lilly, Gilead, Exact Sciences, and CorEvitas, LLC, and has received investigator-initiated research support from AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The CorEvitas (formerly Corrona) LLC dataset is based on a large North American multicenter study adhering to a number of institutional review boards, with complex logistics. Patients did not provide consent to raw data sharing during the data collection for this purpose, and the CorEvitas data-sharing policies do not permit raw data sharing for this purpose. An aggregated limited dataset from the current approved analyses is available to qualified investigators with an approved protocol. Data requests may be sent to CorEvitas, LLC, represented by Dr. Jeffrey D. Greenberg MD, MPH, NYU School of Medicine, New York, NY, e-mail jgreenberg@corevitas.com.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}